Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Splicing factor 3b subunit 5 (SF3B5) is a highly conserved protein component of the SF3B complex, which is part of the U2 small nuclear ribonucleoprotein (snRNP) involved in pre-mRNA splicing within the spliceosome[3][6]. SF3B5 plays a key role in stabilizing the interaction between U2 snRNA and the branch site of pre-mRNA, a critical step for accurate splice site selection and mRNA processing[3][6]. In addition to its core function in RNA splicing, SF3B5 has been shown in metazoans (e.g., Drosophila) to act as a subunit of the Spt-Ada-Gcn5 acetyltransferase (SAGA) transcriptional coactivator complex, where it mediates gene expression activation independently of its splicing role[1][2][4]. SF3B5 is essential for organismal development and cell viability; disruption can cause embryonic lethality and transcriptional defects, and is associated with specific human diseases such as certain congenital syndromes and cancer[6]. There are currently no known direct drugs or clinical biomarkers associated specifically with SF3B5.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Splicing factor 3b subunit 5 (SF3B5).